Literature DB >> 6373615

Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans.

J J Pollock, L Denepitiya, B J MacKay, V J Iacono.   

Abstract

Human parotid saliva histidine-rich polypeptides exerted antifungal activity against Candida albicans at concentrations similar to the known antifungal activity of the imidazole antibiotics. Inhibition of both growth and viability could be demonstrated by optical density monitoring and plating assays. Inhibition of growth was observed to be greatest when the histidine-rich polypeptides were added to the inoculum before addition to the growth media. However, complete inhibition by these polypeptides was still noted during active growth at turbidities of C. albicans corresponding to 10(6) CFU/ml. At higher cell densities, growth was delayed but not halted under the experimental conditions investigated. Candidacidal activity was observed with both growing and nongrowing cells. With respect to the latter, reaction of cells in buffer with the histidine-rich polypeptides for a period of 30 min resulted in killing of greater than 90% of two different strains of C. albicans, whereas a third strain was found to be less susceptible. Moreover, the kinetics of loss of cell viability correlated with the loss of potassium from the cells. In addition to the histidine-rich polypeptides, hen egg white lysozyme, poly-L-lysine, and poly-L-histidine affected C. albicans. Both of the polyamino acids completely inhibited the growth of the yeast whereas lysozyme was not as potent. Where delays in growth were observed for all of these agents, including the histidine-rich polypeptides, turbidities reached those of untreated controls after a 24-h period. Enhanced effects were noted if C. albicans was preincubated with these agents in 0.025 2-(N-morpholino)-ethanesulfonic acid buffer, pH 5.2, before growth in the yeast synthetic medium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373615      PMCID: PMC263673          DOI: 10.1128/iai.44.3.702-707.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  The significance of Candida albicans in denture stomatitis.

Authors:  E Budtz-Jörgensen
Journal:  Scand J Dent Res       Date:  1974

2.  Mode of action of clotrimazole.

Authors:  K Iwata; H Yamaguchi; T Hiratani
Journal:  Sabouraudia       Date:  1973-07

3.  The ultrastructure of Candida albicans after in vitro treatment with miconazole.

Authors:  S De Nollin; M Borgers
Journal:  Sabouraudia       Date:  1974-11

4.  Electron microscopic studies on the mechanism of action of clotrimazole on Candida albicans.

Authors:  K Iwata; Y Kanda; H Yamaguchi; M Osumi
Journal:  Sabouraudia       Date:  1973-11

5.  The oral distribution of candida in denture stomatitis.

Authors:  J C Davenport
Journal:  Br Dent J       Date:  1970-08-18       Impact factor: 1.626

6.  Oral candidosis.

Authors:  T Lehner
Journal:  Dent Pract Dent Rec       Date:  1967-02

7.  The action of miconazole of the growth of Candida albicans.

Authors:  H Van Den Bossche; G Willemsens; J M Van Cutsem
Journal:  Sabouraudia       Date:  1975-03

8.  Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis.

Authors:  C H Kirkpatrick; I Green; R R Rich; A L Schade
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

9.  Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes.

Authors:  R I Lehrer; K M Ladra; R B Hake
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

10.  Effect of some proteins on the yeast cell membrane.

Authors:  D A Yphantis; J L Dainko; F Schlenk
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

View more
  49 in total

1.  Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.

Authors:  D M Rothstein; P Spacciapoli; L T Tran; T Xu; F D Roberts; M Dalla Serra; D K Buxton; F G Oppenheim; P Friden
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease.

Authors:  H Gusman; J Travis; E J Helmerhorst; J Potempa; R F Troxler; F G Oppenheim
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Dialysis unmasks the fungicidal properties of glandular salivary secretions.

Authors:  Eva J Helmerhorst; Bianca Flora; Robert F Troxler; Frank G Oppenheim
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

4.  Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5.

Authors:  C Gyurko; U Lendenmann; R F Troxler; F G Oppenheim
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

5.  Poly L-histidine. A potent stimulator of superoxide generation in human blood leukocytes.

Authors:  I Ginsburg; R Borinski; M Sadovnic; Y Eilam; K Rainsford
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

6.  Inactivation of herpes simplex virus types 1 and 2 by synthetic histidine peptides.

Authors:  J J Docherty; J J Pollock
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

7.  Host-derived pentapeptide affecting adhesion, proliferation, and local pH in biofilm communities composed of Streptococcus and Actinomyces species.

Authors:  Mirva Drobni; Tong Li; Carina Krüger; Vuokko Loimaranta; Mogens Kilian; Lennart Hammarström; Hans Jörnvall; Tomas Bergman; Nicklas Strömberg
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

8.  Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides.

Authors:  Slavena Vylkova; Xuewei S Li; Jennifer C Berner; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 9.  Midkine in host defence.

Authors:  A Gela; S Jovic; S L Nordin; A Egesten
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

10.  The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions?

Authors:  H T Dougall; L Smith; C Duncan; N Benjamin
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.